Serum paraoxonase and arylesterase activities throughout normal pregnancy;Normal gebelik süresince serum paraoksonaz ve arilesteraz aktiviteleri

Nobel Medicus

Volumn 7, Issue 1, 2011, Pages 49-55

  Sarandöl, Emre ^a   Dirican, Melahat ^a   Eröz, Esma ^a   Kirhan, Emine ^a   Serdar, Zehra ^a   Uncu, Gürkan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Hyperlipidemia; Lipid; Oxidative stress; Paraoxonase; Pregnancy

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; OXIDATION; PREGNANCY; PREGNANT WOMAN; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 79956350272     PISSN: 13052381     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Costa LG, Cole TB, Jarvik GP, Furlong CE. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med 2003; 54: 371-392.
2. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase: Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991;19: 100-106.
3. Cao H, Girard-Globa A, Berthezene F, Moulin P. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-R polymorphism. J Lipid Res 1999; 40: 133-139.
4. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 473-480.
5. Mackness MI, Arrol S, Abbott CA, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-135.
6. Aviram M, Rosenblat M, Bisgaier CL, et al. Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581-1590.
7. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. araoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7: 69-76.
8. van Himbergen TM, van Tits LJ, Ter Avest E, et al. Paraoxonase (PON1) is associated with familial combined hyperlipidemia. Atherosclerosis 2008; 199: 87-94.
9. Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008; 115: 874-881.
10. Lippi G, Albiero A, Montagnana M, et al. Lipid and lipoprotein profile in physiological pregnancy. Clin Lab 2007; 53: 173-177.
11. Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 1999; 13: 347-352.
12. Roes EM, Hendriks JC, Raijmakers MT, et al. A longitudinal study of antioxidant status during uncomplicated and hypertensive pregnancies. Acta Obstet Gynecol Scand 2006; 85: 148-155.
13. Chen X, Scholl TO. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr Diab Rep 2005; 5: 282-288.
14. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005; 60: 807-816.
15. Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol 2002; 57: 609-613.
16. Castelao JE, Gago-Dominguez M. Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses 2008; 71: 39-44.
17. Roy AC, Loke DF, Saha N, et al. Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study. Gynecol Obstet Invest 1994; 38: 10-13.
18. Carpintero A, Sánchez-Martín MM, Cabezas-Delamare MJ, Cabezas JA. Variation in serum arylesterase, beta-glucuronidase, cathepsin L and plasminogen activators during pregnancy. Clin Chim Acta 1996 29; 255: 153-164.
19. Ferré N, Camps J, Fernández-Ballart J, et al. Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy. Clin Chem Lab Med 2006; 44: 880-882.
20. Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-1138.
21. Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391-395.
22. Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991; 28: 504-508.
23. Wang YP, Walsh SW, Guo JD, Zhang JY. Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 1991; 165: 1690-1694.
24. Guven S, Alver A, Mentese A, et al. The novel ischemia marker 'ischemia-modified albumin' is increased in normal pregnancies. Acta Obstet Gynecol Scand 2009; 88: 479-482.
25. Belo L, Caslake M, Santos-Silva A, et al. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis 2004; 177: 391-399.
26. Lain KY, Markovic N, Ness RB, Roberts JM. Effect of smoking on uric acid and other metabolic markers throughout normal pregnancy. J Clin Endocrinol Metab 2005; 90: 5743-5746.
27. Zachara BA, Wardak C, Didkowski W, Maciag A, Marchaluk E. Changes in blood selenium and glutathione concentrations and glutathione peroxidase activity in human pregnancy. Gynecol Obstet Invest 1993; 35: 12-17.
28. Chen X, Scholl TO, Leskiw MJ, Donaldson MR, Stein TP. Association of glutathione peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy. J Clin Endocrinol Metab 2003; 88: 5963-5968.